全文获取类型
收费全文 | 3006篇 |
免费 | 227篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 80篇 |
妇产科学 | 42篇 |
基础医学 | 455篇 |
口腔科学 | 247篇 |
临床医学 | 271篇 |
内科学 | 607篇 |
皮肤病学 | 77篇 |
神经病学 | 300篇 |
特种医学 | 52篇 |
外科学 | 289篇 |
综合类 | 13篇 |
预防医学 | 350篇 |
眼科学 | 47篇 |
药学 | 216篇 |
中国医学 | 25篇 |
肿瘤学 | 143篇 |
出版年
2024年 | 4篇 |
2023年 | 56篇 |
2022年 | 97篇 |
2021年 | 130篇 |
2020年 | 95篇 |
2019年 | 136篇 |
2018年 | 153篇 |
2017年 | 102篇 |
2016年 | 115篇 |
2015年 | 163篇 |
2014年 | 189篇 |
2013年 | 205篇 |
2012年 | 298篇 |
2011年 | 317篇 |
2010年 | 163篇 |
2009年 | 123篇 |
2008年 | 170篇 |
2007年 | 158篇 |
2006年 | 137篇 |
2005年 | 100篇 |
2004年 | 81篇 |
2003年 | 80篇 |
2002年 | 75篇 |
2001年 | 5篇 |
2000年 | 2篇 |
1999年 | 8篇 |
1998年 | 6篇 |
1997年 | 9篇 |
1996年 | 8篇 |
1995年 | 7篇 |
1994年 | 5篇 |
1993年 | 7篇 |
1990年 | 2篇 |
1989年 | 4篇 |
1988年 | 6篇 |
1987年 | 5篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1983年 | 2篇 |
1977年 | 3篇 |
1975年 | 2篇 |
1973年 | 6篇 |
1972年 | 3篇 |
1968年 | 1篇 |
1967年 | 1篇 |
1966年 | 2篇 |
1964年 | 1篇 |
1957年 | 1篇 |
1955年 | 1篇 |
1924年 | 1篇 |
排序方式: 共有3256条查询结果,搜索用时 31 毫秒
1.
John Lennon Silva Cunha Amanda Almeida Leite Thamiris de Castro Abrantes Lorena Passoni Vervloet Thayn Melo de Lima Morais Gerson de Oliveira Paiva Neto Tatiana Nayara Librio Kimura Snia Maria Soares Ferreira Ricardo Luiz Cavalcanti de Albuquerque‐Júnior Aline Corrêa Abraho Mario Jos Romaach Bruno Augusto Benevenuto de Andrade Oslei Paes de Almeida Ciro Dantas Soares 《Journal of cutaneous pathology》2021,48(1):24-33
2.
The prevalence of bad self-rated health (SRH) varies considerably across countries. Here we present the results of a cross-national comparative study based on the data of National Health Surveys conducted in France and Italy. According to these data, 11% of the Italian and 6% of the French adult population aged between 45 and 74 rate their health as bad or very bad. This gap may result from differences in population structure regarding the individual characteristics (sociodemographic characteristics, diseases and disabilities, lifestyle, and others) that impact on SRH i.e., a structural effect. It may also be that the link between these characteristics and SRH is “country-specific” i.e., a contextual effect. We use logistic regression models to assess the contribution of both explanations. We find that the structural effect plays a prominent role in the higher prevalence of bad SRH in Italy compared to France. 相似文献
3.
4.
Thomas Wlfel Aline Van Pel Vincent Brichard Jrg Schneider Barbara Seliger Karl-Hermann Meyer Zum Büschenfelde Thierry Boon 《European journal of immunology》1994,24(3):759-764
A number of cytolytic T lymphocyte (CTL) clones derived from several melanoma patients have been found to recognize a majority of melanomas from HLA-A2 patients. We have reported previously that two such CTL clones recognize a product of the tyrosinase gene that is presented by HLA-A2. Here we show that one of these CTL clones recognizes a peptide encoded by the first nine amino acids of the putative signal sequence of tyrosinase. The other CTL clone recognizes a different tyrosinase peptide corresponding to amino acids 368–376. Both peptides contain consensus motifs of HLA-A2 binding peptides. 相似文献
5.
The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons 总被引:24,自引:0,他引:24
Aline Dumuis Michèle Sebben Joël Bockaert 《Naunyn-Schmiedeberg's archives of pharmacology》1989,340(4):403-410
Summary We have previously shown that a non-classical 5-hydroxytryptamine (5-HT4) receptor mediates the stimulation of adenylate cyclase activity in mouse embryo colliculi neurons in primary culture. The pharmacological characteristics of this receptor exclude the possibility that it belongs to the known 5-HT1, 5-HT2 or 5-HT3 receptor types. Here we report that this 5-HT receptor can be stimulated by 4-amino-5-chloro-2-methoxy substituted benzamide derivatives. All these compounds have been reported to be potent stimulants of gastrointestinal motility and some of them are 5-HT3 receptor antagonists. The rank order of potency of these substituted benzamide derivatives in stimulating cAMP formation was: cisapride > BRL 24924 > 5-HT > zacopride > BRL 20627 > metoclopramide. The non-additivity of benzamide and 5-HT activities suggests that 5-HT and the substituted benzamide derivatives act on the same receptor. Only ICS 205930, a recognized 5-HT3 receptor antagonist, competitively antagonized the stimulatory effect of cisapride, zacopride and BRL 24924. However, its pK
i (6–6.3) for this new receptor was very different from its pK
i for 5-HT3 receptors (pK
i = 8 –10). Other selective 5-HT3 receptor antagonists with an indole group (BRL 43694 and GR 38032F), with a benzoate group (cocaïne, MDL 72222) or with a piperazine group (quipazine) were ineffective in reversing the stimulatory effect of benzamide derivatives. Exposure of neuronal cells to potent agonists at this receptor such as BRL 24924 rapidly reduces its capacity to stimulate cAMP production. For example, a preincubation of 10 min with BRL 24924 (100 mol/l) reduced by 42% the ability of 5-HT to stimulate cAMP production. Cross-desensitization occurs between the effects of 5-HT and benzamides. The unique pharmacology of these nonclassical 5-HT receptors that we propose to call 5-HT4 is very close and even identical to the pharmacology of the high affinity 5-HT receptors involved in the indirect stimulation of smooth muscle in the guinea pig ileum. These receptors are different from the 5-HT3 receptors also present in guinea pig ileum.Send offprint requests to A. Dumuis at the above address 相似文献
6.
An allergic agranulocytosis induced by amidopyrine and triggered by noramidopyrine was studied. Leucoagglutinating and leucocytotoxic antibody, active only in the presence of the drug, was demonstrated. The antibody was stable, giving a titre from 1·34 to 1·62 and was present in the IgM (19S globulin) and in the IgG (7S globulin) serum fractions. The site of drug fixation was studied by use of iodoantipyrine labelled with 131I; a stable fixation was demonstrated on to the IgM and IgG globulins. Special emphasis is given to cross-reaction with compounds related to amidopyrine. 相似文献
7.
Liciano Contu Inceborg Deschamps Henri Lestradet Jacques Hors Michel Schmid Marc Busson Alain Benajam Aline Marcelli-Barge Jean Dausset 《Tissue antigens》1982,20(2):123-140
Fifty-three families with at least one IDD patient were genotyped for 5 markers of the HLA complex including Bf and DR. In 8 families one of the parents was also affected and in 12 families more than two children were diseased. In total, 76 patients were genotyped. Their haplotypes were compared with those of 106 unrelated controls (the parents of 53 genotyped families).
The data support a model of inheritance comprising at least two closely linked specifically "diabetic" loci (most of the time marked by B18, BfFl, DR3 and B15, BfS, DR4) and a non-specifically "diabetic" haplotype favouring auto-immunisation (most of the time marked by B8, BfS, DR3). This model is discussed in the light of the presented data and of those of the literature. 相似文献
- 1)
Three haplotypes or segments of them (A2, Cw3, B15, BfS, DR4; Aw30, Cw5, B18, BfF I, DR3; and Al, Cw7, B8, BfS, DR3) were found more frequently in IDD patients.
- 2)
Measured by the 6 formula, the association of the postulated IDD susceptibility gene was very strong with the D-end of two of these haplotypes: BfF1, DR3 and BfS, DR4. However, the association was weak with the DR3 of the haplotype Al, Cw7, B8, BfS, DR3.
- 3)
An excess of HLA-identical affected siblings was found.
- 4)
An excess of DR3/DR4 heterozygotes was observed. By contrast, the observed frequency of patients homozygous for DR3 or DR4 was not increased, but even slightly decreased.
The data support a model of inheritance comprising at least two closely linked specifically "diabetic" loci (most of the time marked by B18, BfFl, DR3 and B15, BfS, DR4) and a non-specifically "diabetic" haplotype favouring auto-immunisation (most of the time marked by B8, BfS, DR3). This model is discussed in the light of the presented data and of those of the literature. 相似文献
8.
Carlo Cervia Jakob Nilsson Yves Zurbuchen Alan Valaperti Jens Schreiner Aline Wolfensberger Miro E. Raeber Sarah Adamo Sebastian Weigang Marc Emmenegger Sara Hasler Philipp P. Bosshard Elena De Cecco Esther Bächli Alain Rudiger Melina Stüssi-Helbling Lars C. Huber Annelies S. Zinkernagel Onur Boyman 《The Journal of allergy and clinical immunology》2021,147(2):545-557.e9
- Download : Download high-res image (64KB)
- Download : Download full-size image
9.
Acute inflammatory response to endotoxin in mice and humans 总被引:3,自引:0,他引:3
Copeland S Warren HS Lowry SF Calvano SE Remick D;Inflammation the Host Response to Injury Investigators 《Clinical and diagnostic laboratory immunology》2005,12(1):60-67
Endotoxin injection has been widely used to study the acute inflammatory response. In this study, we directly compared the inflammatory responses to endotoxin in mice and humans. Escherichia coli type O113 endotoxin was prepared under identical conditions, verified to be of equal biological potency, and used for both mice and humans. The dose of endotoxin needed to induce an interleukin-6 (IL-6) concentration in plasma of approximately 1,000 pg/ml 2 h after injection was 2 ng/kg of body weight in humans and 500 ng/kg in mice. Healthy adult volunteers were injected intravenously with endotoxin, and male C57BL/6 mice (n=4 to 12) were injected intraperitoneally with endotoxin. Physiological, hematological, and cytokine responses were determined. Endotoxin induced a rapid physiological response in humans (fever, tachycardia, and slight hypotension) but not in mice. Both mice and humans exhibited lymphopenia with a nadir at 4 h and recovery by 24 h. The levels of tumor necrosis factor (TNF) and IL-6 in plasma peaked at 2 h and returned to baseline levels by 4 to 6 h. IL-1 receptor antagonist RA and TNF soluble receptor I were upregulated in both mice and humans but were upregulated more strongly in humans. Mice produced greater levels of CXC chemokines, and both mice and humans exhibited peak production at 2 h. These studies demonstrate that although differences exist and a higher endotoxin challenge is necessary in mice, there are several similarities in the inflammatory response to endotoxin in mice and humans. 相似文献
10.
Factors affecting the determination of threshold doses for allergenic foods: how much is too much? 总被引:15,自引:0,他引:15
Steve L Taylor Susan L Hefle Carsten Bindslev-Jensen S Allan Bock A Wesley Burks Lynn Christie David J Hill Arne Host Jonathan O'b Hourihane Gideon Lack Dean D Metcalfe Denise Anne Moneret-Vautrin Peter A Vadas Fabienne Rance Daniel J Skrypec Thomas A Trautman Ingrid Malmheden Yman Robert S Zeiger 《The Journal of allergy and clinical immunology》2002,109(1):24-30
BACKGROUND: Ingestion of small amounts of an offending food can elicit adverse reactions in individuals with IgE-mediated food allergies. The threshold dose for provocation of such reactions is often considered to be zero. However, because of various practical limitations in food production and processing, foods may occasionally contain trace residues of the offending food. Are these very low, residual quantities hazardous to allergic consumers? How much of the offending food is too much? Very little quantitative information exists to allow any risk assessments to be conducted by the food industry. OBJECTIVE: We sought to determine whether the quality and quantity of existing clinical data on threshold doses for commonly allergenic foods were sufficient to allow consensus to be reached on establishment of threshold doses for specific foods. METHODS: In September 1999, 12 clinical allergists and other interested parties were invited to participate in a roundtable conference to share existing data on threshold doses and to discuss clinical approaches that would allow the acquisition of that information. RESULTS: Considerable data were identified in clinical files relating to the threshold doses for peanut, cows' milk, and egg; limited data were available for other foods, such as fish and mustard. CONCLUSIONS: Because these data were often obtained by means of different protocols, the estimation of a threshold dose was very difficult. Development of a standardized protocol for clinical experiments to allow determination of the threshold dose is needed. 相似文献